MARKET

DBVT

DBVT

Dbv Technologies S A
NASDAQ
23.80
+1.58
+7.11%
After Hours: 23.80 0 0.00% 16:00 02/10 EST
OPEN
24.08
PREV CLOSE
22.22
HIGH
24.65
LOW
23.10
VOLUME
343.04K
TURNOVER
--
52 WEEK HIGH
26.19
52 WEEK LOW
3.820
MARKET CAP
1.21B
P/E (TTM)
-4.5369
1D
5D
1M
3M
1Y
5Y
1D
DBV Technologies To Present VITESSE Phase 3 Study Of VIASKIN Peanut Patch Data At AAAAI 2026 Annual Meeting
Benzinga · 11h ago
DBV Technologies to Present New VIASKIN Peanut Patch Data at AAAAI Annual Meeting
Reuters · 11h ago
DBV Technologies Unveils Additional Phase 3 Data for VIASKIN Peanut Patch in Children at AAAAI 2026 Meeting
Reuters · 11h ago
DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting
Barchart · 17h ago
DBV Technologies nimmt am Guggenheim Securities Emerging Outlook: Biotech Summit teil
Reuters · 1d ago
DBV Technologies CEO to Present at Guggenheim Securities Emerging Outlook Biotech Summit
Reuters · 1d ago
DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit
Barchart · 1d ago
Weekly Report: what happened at DBVT last week (0202-0206)?
Weekly Report · 1d ago
More
About DBVT
DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The Company's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The Company operates one subsidiary DBV Technologies Inc. in the United States.

Webull offers DBV Technologies SA - ADR stock information, including NASDAQ: DBVT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DBVT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DBVT stock methods without spending real money on the virtual paper trading platform.